A federal judge has ruled that makers of generic drugs are not protected from lawsuits even if the Food and Drug Administration (FDA) certifies them as the “bioequivalent” of their brand-name predecessors. U.S. District Judge Berle M. Schiller refused to dismiss a suit brought by consumers who were previously taking the brand name antidepressant Wellbutrin but claim they experienced side effects after switching to the generic version, buproprion. The lawsuit claims that Teva Pharmaceuticals and Impax Laboratories, both manufacturers of buproprion, knew of the reported side effects but failed to warn consumers of the differing release rates of the active ingredient in the generic drugs versus the brand name.

Referencing the Supreme Court’s recent decision on Wyeth v. Levine, Schiller wrote in the Teva/Impax decision that generic drug manufacturers have a duty to continuously issue warnings about any new side effects reported even after the drug has been approved. “A generic drug manufacturer is not absolved of liability because the FDA has approved its generic product,” he continued.

Buproprion isn’t the only generic drug under fire for not adequately warning consumers of potential side effects caused by subtle differences when switching from a brand name drug to its generic equivalent. In 2009, generic versions of the anti-seizure drug Keppra from numerous manufacturers were approved for marketing in the United States. Consumers who were managing their seizure disorders with Keppra quickly found that switching to the less expensive generic versions caused their seizures to return or created new conditions, such as severe headaches.

Health care professionals recommend that special care be given when patients switch from a brand-name seizure medication to a generic one, or even switching between two different generic drugs.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Generic drug savings may come at a price

Think generic medications are just the same as their brand name equivalents? Think again. Generics may...

New iPhone app helps epileptics monior seizures,...

People living with epilepsy can now keep a diary of their seizures on their iPhone, thanks to the new...

Switching from Keppra to generic can make you sick

Switching from brand name Keppra to generic Keppra (levetiracetam) to treat her epileptic seizures made...

Experimental SmartWatch offers peace of mind to...

A fully functional prototype of a wristwatch-style device that can detect myoclonic and grand mal...

Free toolkit available to parents of children...

Parents of children diagnosed with epilepsy have the daunting responsibility of helping their child...

Approval of GlaxoSmithKline, Valeant new epilepsy drug...

Despite a "thumbs-up" from a Food and Drug Administration (FDA) advisory panel on GlaxoSmithKline and...

A positive manner

Several years ago my brother and sister -in-law were in a terrible car accident. My sister in-law was paralyzed from her neck down. Beasley Allen handled the case for my brother to see to it that my sister-in-law received the proper and necessary care she needed. I appreciate the attorneys and staff of Beasley Allen in handling this matter quickly and in a positive manner. Good job Beasley Allen!!

—Joan